Kuan Chih Chen

CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan.

Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan.

Tung Bao Corp. engages in the manufacture and sale of chemical products. It operates through three segments: De-aromatics Solvent, Petro-Chemical Acetylene, and E-grade Hydrogen. The Solvents is used in machinery, dry cleaning, carrier, metal processing, anti-rust, and lubricants. The Petro-chemical Acetylene is applied in cutting, welding, and heat treatment. The E-grade hydrogen aims at solar processing, light-emitting diode, semiconductor and petro chemical industries. Tung Bao was founded on September 16, 1987 and is headquartered in New Taipei, Taiwan.